Follow this preprint

Predicting Success of Phase III Trials in Oncology

Stephan Hegge, Markus Thunecke, Matthias Krings, Léonard Ruedin, Jan Saputra Müller, Paul von Bünau
doi: https://doi.org/10.1101/2020.12.15.20248240
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Article Information

doi 
https://doi.org/10.1101/2020.12.15.20248240
History 
  • December 16, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Stephan Hegge, PhD1,#,
  2. Markus Thunecke, PhD2,
  3. Matthias Krings, PhD2,
  4. Léonard Ruedin, MSc3,
  5. Jan Saputra Müller, MSc4 and
  6. Paul von Bünau, PhD3
  1. 1Hegge Holding UG, Kopernikusstr. 24, 10247 Berlin
  2. 2Catenion GmbH, Münzstrasse 18, 10278 Berlin, Germany
  3. 3idalab GmbH, Potsdamer Straße 68, 10785 Berlin, Germany
  4. 4AskBy GmbH, Boxhagener Str. 18, 10245 Berlin
  1. ↵#corresponding author Email: StephanHegge{at}gmx.de
Back to top
Posted December 16, 2020.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML

Supplementary Material

Data/Code
Email
Predicting Success of Phase III Trials in Oncology
Stephan Hegge, Markus Thunecke, Matthias Krings, Léonard Ruedin, Jan Saputra Müller, Paul von Bünau
medRxiv 2020.12.15.20248240; doi: https://doi.org/10.1101/2020.12.15.20248240
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

1

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

0

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.